Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
---|---|---|---|---|---|---|
![]() |
Fig.5 K, L
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF28 (in situ hybridization) |
|
|||
![]() |
Fig.6 G H
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF28-33/34 (immunohistochemistry) |
|
|||
![]() |
Fig.9 a b c
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF29/30 (immunohistochemistry) |
|
|||
![]() |
Fig.9 a b c
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF29/30 (in situ hybridization) |
|
|||
![]() |
Fig.11 C, D
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF31 (in situ hybridization) |
|
|||
![]() |
Fig.6 K, L.
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF37/38 (immunohistochemistry) |
|
|||
![]() |
Fig.6 M, N
Martin BL and Harland RM (2006) |
Xla Wt + Dre.lbx1
NF41 (immunohistochemistry) |
|